Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.66 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.66 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.66 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.66 |
| ▸ | CA9 | Q16790 | 4/20 | 0.65 |
| ▸ | CA12 | O43570 | 3/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27872854 | 0.89 | CA9 (0.61) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL9719462 | 0.85 | F2 (0.68) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL23808946 | 0.82 | F2 (0.61) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL14176753 | 0.82 | F2 (0.61) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL15631068 | 0.82 | NPC1 (0.73) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL13384871 | 0.80 | NPC1 (0.71) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL12901867 | 0.80 | MAPT (0.61) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL14419936 | 0.80 | NPC1 (0.71) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL9019288 | 0.80 | NPC1 (0.71) | F2PRSS1PRSS2PRSS3CA9 | |
| SCHEMBL13602555 | 0.80 | NPC1 (0.71) | F2PRSS1PRSS2PRSS3CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018013999-A1 | NON-NUCLEOSIDIC SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM CHEMICALS LLC (US) | 2018-01-18 | — | — | WO | disclosed |
| US-20120141402-A1 | NANOSCOPIC HAIR CARE PRODUCTS | BOSTON COSMETICS, LLC | 2012-06-07 | — | — | US | disclosed |
| US-7968084-B2 | A Hair dye IN AN INTIMATE RELATIONSHIP TO A POLYMERIC NANOSTRUCTURE having hair-reactive functional groups to be covalently bound to or immobilized onto or in the hair | BOSTON COSMETICS, LLC (US) | 2011-06-28 | — | — | US | disclosed |
| US-20080138817-A1 | Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same | CREDIA JAPAN CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| US-7282575-B2 | Functional peptide nucleic acid monomer and process for producing the same | CREDIA JAPAN CO., LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138817-A1 | Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same | NSUN3, RNGTT, NSUN2 | F2 2109/4885PRSS1 4194/4885PRSS2 3342/4885 |
| US-20120141402-A1 | NANOSCOPIC HAIR CARE PRODUCTS | TYR, CUTA, SUCLG1 | F2 942/4885PRSS1 2956/4885PRSS2 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.